Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1969 1
1970 3
1972 2
1973 1
1974 1
1975 2
1979 1
1981 1
1983 2
1984 2
1986 1
1987 1
1989 1
1990 3
1991 2
1993 1
1995 1
1996 1
1997 2
1999 2
2000 3
2001 4
2002 7
2003 8
2004 10
2005 7
2006 4
2007 6
2008 4
2009 2
2010 3
2011 2
2012 1
2013 7
2014 2
2015 4
2016 5
2017 2
2018 8
2019 4
2020 12
2021 7
2022 10
2023 6
2024 13
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Unleashing precision: A review of targeted approaches in pleural mesothelioma.
Occhipinti M, Brambilla M, Di Liello R, Ambrosini P, Lobianco L, Leporati R, Salvarezza M, Vitiello F, Marchesi S, Manglaviti S, Beninato T, Mazzeo L, Proto C, Prelaj A, Ferrara R, Della Corte CM, Lo Russo G, de Braud F, Ganzinelli M, Viscardi G. Occhipinti M, et al. Among authors: marchesi s. Crit Rev Oncol Hematol. 2024 Nov;203:104481. doi: 10.1016/j.critrevonc.2024.104481. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159705 Free article. Review.
Anaphylaxis to persimmon.
Prandini M, Marchesi S. Prandini M, et al. Among authors: marchesi s. Allergy. 1999 Aug;54(8):897. doi: 10.1034/j.1398-9995.1999.00273.x. Allergy. 1999. PMID: 10485400 No abstract available.
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. Randon G, et al. Among authors: marchesi s. Lancet Oncol. 2024 Dec;25(12):1539-1550. doi: 10.1016/S1470-2045(24)00580-1. Epub 2024 Nov 15. Lancet Oncol. 2024. PMID: 39557058 Clinical Trial.
Delegation of implementation in project aid.
Marchesi S, Masi T. Marchesi S, et al. Rev Int Organ. 2021;16(3):655-687. doi: 10.1007/s11558-020-09396-9. Epub 2020 Nov 21. Rev Int Organ. 2021. PMID: 38624514 Free PMC article.
164 results